Growth hormone & endocrine research

Tesamorelin

Authorised product

Synthetic GHRH analogue peptide

Research material. Not for human or animal consumption.

Research overview

Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH): the full 44-amino-acid human sequence with a trans-3-hexenoyl group added to the N-terminus. The modification protects it from rapid breakdown by dipeptidyl peptidase-4 while keeping its action on pituitary GHRH receptors, raising growth hormone and IGF-1 within the normal feedback system. Randomised trials in adults with HIV-associated lipodystrophy found reduced visceral abdominal fat, leading to authorised Egrifta products for that narrow indication.

EVIDENCE LEVEL Authorised product

An authorisation applies to at least one defined finished product in a stated jurisdiction; it does not apply automatically to this catalogue material.

Molecule classSynthetic GHRH analogue peptide
Batch documentationAsk for the batch COA
Research fieldGrowth Hormone & Endocrine Research
EnquiriesResearch quotation available

Questions about Tesamorelin

PRODUCT QUESTIONS
What is Tesamorelin?

Tesamorelin is a synthetic growth hormone releasing hormone (GHRH) analogue peptide used in endocrine research, particularly studies of visceral adiposity in antiretroviral treated populations.

What is Tesamorelin used for in research?

A GHRH analogue with randomised evidence of reduced visceral abdominal fat in adults with HIV associated lipodystrophy; defined finished products are authorised for that specific context, not general weight loss.

What research has been published on Tesamorelin?

Tesamorelin is a synthetic GHRH analogue whose clinical evidence centres on one population. Randomised studies in antiretroviral treated adults with HIV associated lipodystrophy found reduced visceral adipose tissue, with some lipid and liver fat findings also studied. FDA authorised Egrifta WR/SV products are indicated to reduce excess abdominal fat in HIV infected adults with lipodystrophy; this does not establish authorisation for general weight loss or for a catalogue material.

What batch documentation should accompany Tesamorelin?

Tesamorelin: Ask for the COA and analytical reports for the batch being quoted. For a 44 residue modified peptide, ask for mass spectrometry confirming the hexenoyl group, HPLC purity that resolves the unmodified GHRH sequence, peptide content and the acetate salt content.

How should Tesamorelin storage conditions be assessed?

Lyophilised Tesamorelin is stored at 2°C to 8°C, protected from light. Its methionine can oxidise and the long chain can aggregate in solution, so dissolved material is kept cold and used promptly.

Buy real Tesamorelin UK?

OrientSciences supplies Tesamorelin to research customers in the UK. The Tesamorelin record lists it as a synthetic GHRH analogue peptide, in the Growth Hormone & Endocrine Research range. To check that what you receive is what you ordered, ask for the batch COA and analytical reports before you order, and compare them with the specification. Use the research quotation form on this page, giving the quantity you need and your UK delivery address.

RESEARCH ENQUIRIES

Request a quotation

Enquire about Tesamorelin and the documentation for the available batch.

Request a quotation
Share record